Pure Global

Rapid Syphilis Antibody Test-Device - India CDSCO Medical Device Registration

Rapid Syphilis Antibody Test-Device is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2022/000068_25e1c834f2a39e36cbd8237e855fb20a_d11a2ffb70a990504034fe99bb259b10. This device is marketed under the brand name Rapichek Syphilis. The license holder is Oxalis Diagnostics Pvt. Ltd, and it is classified as Device Class Class D. The approving authority is Central Drug Standards Control Organization, West Zone.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class D
Rapid Syphilis Antibody Test-Device
UID: MFG/IVD/2022/000068_25e1c834f2a39e36cbd8237e855fb20a_d11a2ffb70a990504034fe99bb259b10

Brand Name

Rapichek Syphilis

Device Class

Class D

Approving Authority

Central Drug Standards Control Organization, West Zone

Product Information

Rapid Syphilis Antibody Test device is a lateral flow chromatographic immunoassay for the qualitative detection of antibodies to Treponema pallidum in human blood/serum/plasma . It is intended to be used by professionals as a screening test and provides a preliminary test result to aid in the diagnosis of infection with Treponema pallidum. Alternative test method(Rapichek Syphilis) should be considered to confirm the test result obtained by this device.

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing